Stock Scorer

Biomerica Inc (BMRA)

Biomerica Inc reported revenue of 987K USD for the quarter ending 28 February 2026, down 11.8% from 1.1M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q1 '26 · ending 28 February 2026 987K -11.8%
Gross Profit Q1 '26 · ending 28 February 2026 -44K -110.1%
Operating Income Q1 '26 · ending 28 February 2026 -1.3M —
Net Income Q1 '26 · ending 28 February 2026 -1.3M —
Cost of Revenue Q1 '26 · ending 28 February 2026 1M -6.3%
Operating Cash Flow Q1 '26 · ending 28 February 2026 -1.2M —
Free Cash Flow Q2 '24 · ending 31 May 2024 -1.1M —
Shares Outstanding Q1 '26 · ending 28 February 2026 3M +40.7%
EPS Q1 '26 · ending 28 February 2026 -1.58 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-05-31 5.3M-5.1M-5M—
20242024-05-31 5.4M-6.4M-6M-5.4M
20232023-05-31 5.3M-7.2M-7.1M-5.5M
20222022-05-31 18.9M-4.5M-4.5M-536K
20212021-05-31 7.2M-7.5M-7.4M-5.4M
20202020-05-31 6.7M-2.7M-2.7M-4.3M
20192019-05-31 5.2M-2.4M-2.4M-2.3M
20182018-05-31 5.6M-1.5M-1.5M-1.3M
20172017-05-31 5.8M-954.6K-908.6K-818.9K
20162016-05-31 5.1M-827K-1.5M-300.3K

Every period

Revenue Quarterly

PeriodEndingRevenue
Q3 '262026-02-28987K
Q2 '262025-11-301.2M
Q1 '262025-08-311.4M
Q4 '252025-05-31749K
Q3 '252025-02-281.1M
Q2 '252024-11-301.6M
Q1 '252024-08-311.8M
Q4 '242024-05-311.1M
Q3 '242024-02-291M
Q2 '242023-11-301.6M
Q1 '242023-08-311.7M
Q4 '232023-05-311.1M
Q3 '232023-02-281.1M
Q2 '232022-11-301.5M
Q1 '232022-08-311.6M
Q4 '222022-05-315.3M
Q3 '222022-02-287.7M
Q2 '222021-11-304.6M
Q1 '222021-08-311.3M
Q4 '212021-05-311.1M

Gross Profit Quarterly

PeriodEndingGross Profit
Q3 '262026-02-28-44K
Q2 '262025-11-3051K
Q1 '262025-08-31424K
Q3 '252025-02-2819K
Q2 '252024-11-30437K
Q1 '252024-08-31289K
Q4 '242024-05-3123K
Q3 '242024-02-29-149K
Q2 '242023-11-30325K
Q1 '242023-08-31412K
Q4 '232023-05-3129K
Q3 '232023-02-28120K
Q2 '232022-11-30352K
Q1 '232022-08-31-55K
Q4 '222022-05-31621K
Q3 '222022-02-281.7M
Q2 '222021-11-30771.8K
Q1 '222021-08-31-89K
Q4 '212021-05-3112.9K
Q3 '212021-02-28-73.4K

Operating Income Quarterly

PeriodEndingOperating Income
Q3 '262026-02-28-1.3M
Q2 '262025-11-30-1.4M
Q1 '262025-08-31-1.1M
Q4 '252025-05-31-1.6M
Q3 '252025-02-28-1.2M
Q2 '252024-11-30-993K
Q1 '252024-08-31-1.4M
Q4 '242024-05-31-1.5M
Q3 '242024-02-29-2M
Q2 '242023-11-30-1.6M
Q1 '242023-08-31-1.2M
Q4 '232023-05-31-1.8M
Q3 '232023-02-28-1.7M
Q2 '232022-11-30-1.7M
Q1 '232022-08-31-2.1M
Q4 '222022-05-31-1.8M
Q3 '222022-02-28-107.5K
Q2 '222021-11-30-1.1M
Q1 '222021-08-31-1.5M
Q4 '212021-05-31-1.7M

Net Income Quarterly

PeriodEndingNet Income
Q3 '262026-02-28-1.3M
Q2 '262025-11-30-1.3M
Q1 '262025-08-312K
Q4 '252025-05-31-1.5M
Q3 '252025-02-28-1.2M
Q2 '252024-11-30-950K
Q1 '252024-08-31-1.3M
Q4 '242024-05-31-1.4M
Q3 '242024-02-29-1.9M
Q2 '242023-11-30-1.5M
Q1 '242023-08-31-1.1M
Q4 '232023-05-31-1.8M
Q3 '232023-02-28-1.6M
Q2 '232022-11-30-1.6M
Q1 '232022-08-31-2.1M
Q4 '222022-05-31-1.8M
Q3 '222022-02-28-104.2K
Q2 '222021-11-30-1.1M
Q1 '222021-08-31-1.5M
Q4 '212021-05-31-1.7M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q3 '262026-02-281M
Q2 '262025-11-301.2M
Q1 '262025-08-31956K
Q4 '252025-05-31993K
Q3 '252025-02-281.1M
Q2 '252024-11-301.2M
Q1 '252024-08-311.5M
Q4 '242024-05-311.1M
Q3 '242024-02-291.2M
Q2 '242023-11-301.2M
Q1 '242023-08-311.3M
Q4 '232023-05-311.1M
Q3 '232023-02-28991K
Q2 '232022-11-301.1M
Q1 '232022-08-311.7M
Q4 '222022-05-314.7M
Q3 '222022-02-286M
Q2 '222021-11-303.9M
Q1 '222021-08-311.4M
Q4 '212021-05-311M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q3 '262026-02-28-1.2M
Q2 '262025-11-30-991K
Q1 '262025-08-31-268K
Q4 '252025-05-31-661K
Q3 '252025-02-28-1M
Q2 '252024-11-30-791K
Q1 '252024-08-31-1.3M
Q4 '242024-05-31-1M
Q3 '242024-02-29-1.8M
Q2 '242023-11-30-842K
Q1 '242023-08-31-1.7M
Q4 '232023-05-31-963K
Q3 '232023-02-28-1.7M
Q2 '232022-11-30-1.2M
Q1 '232022-08-31-1.6M
Q3 '222022-02-282.4M
Q2 '222021-11-301.3M
Q1 '222021-08-3175.8K
Q4 '212021-05-31-1M
Q3 '212021-02-28-1.4M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '242024-05-31-1.1M
Q3 '242024-02-29-1.8M
Q2 '242023-11-30-848K
Q1 '242023-08-31-1.7M
Q4 '232023-05-31-963K
Q3 '232023-02-28-1.7M
Q2 '232022-11-30-1.2M
Q1 '232022-08-31-1.6M
Q3 '222022-02-282.3M
Q2 '222021-11-301.3M
Q1 '222021-08-3170.7K
Q4 '212021-05-31-1M
Q3 '212021-02-28-1.4M
Q2 '212020-11-30-1.3M
Q1 '212020-08-31-1.6M
Q4 '202020-05-31-3.5M
Q3 '202020-02-29-458.3K
Q2 '202019-11-30-362K
Q1 '202019-08-31-10.3K
Q4 '192019-05-31-1M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q3 '262026-02-283M
Q2 '262025-11-302.9M
Q1 '262025-08-312.6M
Q3 '252025-02-282.4M
Q2 '252024-11-302.1M
Q1 '252024-08-312.1M
Q3 '242024-02-2916.8M
Q2 '242023-11-3016.8M
Q1 '242023-08-3116.8M
Q3 '232023-02-2813.5M
Q2 '232022-11-3013.5M
Q1 '232022-08-3113.1M
Q3 '222022-02-2812.8M
Q2 '222021-11-3012.6M
Q1 '222021-08-3112.4M
Q3 '212021-02-2811.9M
Q2 '212020-11-3011.8M
Q1 '212020-08-3111.7M
Q3 '202020-02-299.8M
Q2 '202019-11-309.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q3 '262026-02-28-1.58
Q2 '262025-11-30-1.62
Q1 '252024-08-31-3.40
Q4 '242024-05-31-2.84
Q3 '242024-02-29-0.37
Q2 '242023-11-30-0.38
Q1 '242023-08-31-0.41
Q4 '232023-05-31-0.50
Q3 '232023-02-28-0.54
Q2 '232022-11-30-0.43
Q1 '232022-08-31-0.40
Q4 '222022-05-31-0.36
Q3 '222022-02-28-0.35
Q2 '222021-11-30-0.52
Q1 '222021-08-31-0.58
Q4 '212021-05-31-0.62
Q3 '212021-02-28-0.56
Q2 '212020-11-30-0.47
Q1 '212020-08-31-0.37
Q4 '202020-05-31-0.26